HRT Financial’s M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant MBSC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50,000
Closed -$515K 3576
2023
Q1
$515K Hold
50,000
0.01% 1360
2022
Q4
$511K Hold
50,000
0.01% 1398
2022
Q3
$504K Hold
50,000
0.01% 1500
2022
Q2
$498K Hold
50,000
0.01% 1572
2022
Q1
$501K Hold
50,000
﹤0.01% 1694
2021
Q4
$501K Buy
+50,000
New +$501K ﹤0.01% 1774

Other funds holding MBSC.U

HRT Financial's MBSC.U Position: Q2 2023 in Review

HRT Financial sold out of M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant (MBSC.U) in Q2 2023, closing a stake of 50,000 shares — an estimated $515K sold.

HRT Financial first reported a position in MBSC.U in Q4 2021 and held it in 6 quarters. The position peaked at $515K in Q1 2023. 3 funds tracked by Wall St. Rank hold MBSC.U as of Q2 2023.

  • HRT Financial reported no remaining M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 50,000 M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant shares in Q2 2023, an estimated $515K.
  • HRT Financial first reported a position in M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant in Q4 2021 and held it in 6 quarters.
  • HRT Financial's M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position peaked at $515K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held M3-Brigade Acquisition III Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.